REQUEST A DEMO
Total
USD $0.00
Search more companies

Ukay Remedys Private Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Ukay Remedys Private Limited Profile Updated: May 20, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Ukay Remedys Private Limited is an unlisted company, incorporated on 27/05/2008. It has its registered office in the State of Maharashtra, India. Company's corporate identification number (CIN) is U24230MH2008PTC182718 and registration number is 182718. The company is a manufacturing company, it is engaged in chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Legal Address
B/403, Jamana Darshan N. R. Karode Marg, Borivali (West)
Mumbai; Maharashtra; Postal Code: 400092

Contact Details: Purchase the Ukay Remedys Private Limited report to view the information.

Basic Information
Outstanding Shares:
Purchase the Ukay Remedys Private Limited report to view the information.
Registered Capital:
Purchase the Ukay Remedys Private Limited report to view the information.
Incorporation Date:
May 27, 2008
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Independent Director
Purchase this report to view the information.
Independent Director
Company Performance
Financial values in the chart are available after Ukay Remedys Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
-26.03%
Total operating revenue
-26.15%
Operating profit (EBIT)
-25.04%
EBITDA
-14.59%
Net Profit (Loss) for the Period
-33.44%
Total assets
48.58%
Total equity
9.74%
Operating Profit Margin (ROS)
0.02%
Net Profit Margin
-0.14%
Return on Equity (ROE)
-5.76%
Debt to Equity Ratio
5.8%
Quick Ratio
0.05%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?